DOI QR코드

DOI QR Code

Intraventricular Antimicrobial Therapy for Intractable Ventriculitis: Two Case Reports

  • Lee, Ji Weon (Department of Pediatrics, Korea University College of Medicine) ;
  • Yoon, Yoonsun (Department of Pediatrics, Korea University College of Medicine) ;
  • Kim, Sang-Dae (Department of Neurosurgery, Korea University Ansan Hospital) ;
  • Kim, Yun-Kyung (Department of Pediatrics, Korea University College of Medicine)
  • Received : 2021.09.04
  • Accepted : 2022.03.31
  • Published : 2022.04.25

Abstract

It is challenging to treat ventriculitis with parenteral treatment alone in some cases because of the difficulty involved in maintaining an appropriate level of antibiotics in cerebrospinal fluid (CSF). We report two cases of ventriculitis who did not respond to intravenous (IV) antibiotics but were successfully treated with intraventricular antibiotics using IV agents. The first case was a four-month-old male patient with X-linked hydrocephalus. He showed ventriculitis due to Klebsiella pneumoniae not producing extended-spectrum β-lactamase and susceptible to third-generation cephalosporins and gentamicin, following ventriculoperitoneal (VP) shunt. His condition did not improve during the 47 days of treatment with IV cefotaxime and meropenem. We achieved improvement in clinical presentation and CSF profile after three times of intraventricular gentamicin injection. The patient was discharged from the hospital with antiepileptic drugs. The second case was a six-month-old female patient with a history of neonatal meningitis complicated with hydrocephalus at one month of age, VP shunt at two months of age, followed by a methicillin-resistant coagulase-negative staphylococci (CoNS) shunt infection with ventriculitis after the shunt operation. CoNS ventriculitis recurred four weeks later. We failed to treat intractable methicillin-resistant CoNS ventriculitis with IV vancomycin for ten days, and thus intraventricular antimicrobial treatment was considered. Five times of intraventricular vancomycin administration led to improvement in clinical parameters. There were only neurological sequelae of delayed language development but no other major complications. Patients in these two cases responded well to intraventricular antibiotics, with negative CSF culture results, and were successfully treated for ventriculitis without serious complications.

뇌실염은 일반적으로 정맥 내 항생제를 통하여 치료하나, 불응성 뇌실염의 치료는 정맥 내 항생제 치료와 뇌실 내 항생제 치료의 병행이 요구되기도 한다. 이론적으로 항생제의 뇌실 내 투여는 정맥 내 단독 투여보다 뇌척수액에서 더 높은 항생제 농도에 도달할 수 있게 한다. 본 증례 보고는 기존의 전신 항생제 치료에 불응하는 폐렴 간균과 메티실린 내성 표피 포도상 구균에 각각 뇌실 내 겐타마이신과 반코마이신 투여를 통하여 뇌실염을 치료한 2례로서 이후에도 주요 합병증 등이 없어 이를 보고하는 바이다.

Keywords

References

  1. Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Scheld WM, et al. 2017 Infectious Diseases Society of America's clinical practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis 2017;64:e34-65. https://doi.org/10.1093/cid/ciw861
  2. Harris L, Munakomi S. Ventriculitis [Internet]. Treasure Island: StatPearls Publishing; 2021 [cited 2021 Sep 4]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK544332/.
  3. Unhanand M, Mustafa MM, McCracken GH Jr, Nelson JD. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr 1993;122:15-21. https://doi.org/10.1016/S0022-3476(05)83480-8
  4. Ziai WC, Lewin JJ 3rd. Improving the role of intraventricular antimicrobial agents in the management of meningitis. Curr Opin Neurol 2009;22:277-82. https://doi.org/10.1097/WCO.0b013e32832c1396
  5. Nau R, Blei C, Eiffert H. Intrathecal antibacterial and antifungal therapies. Clin Microbiol Rev 2020;33:e00190-19.
  6. Mrowczynski OD, Langan ST, Rizk EB. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: a review and update. Clin Neurol Neurosurg 2018;170:140-58. https://doi.org/10.1016/j.clineuro.2018.05.007
  7. Khan SA, Waqas M, Siddiqui UT, Shamim MS, Nathani KR, Jooma R, et al. Intrathecal and intraventricular antibiotics for postoperative gram-negative meningitis and ventriculitis. Surg Neurol Int 2017;8:226. https://doi.org/10.4103/sni.sni_81_17
  8. Ng K, Mabasa VH, Chow I, Ensom MH. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults. Neurocrit Care 2014;20:158-71. https://doi.org/10.1007/s12028-012-9784-z
  9. Pfausler B, Haring HP, Kampfl A, Wissel J, Schober M, Schmutzhard E. Cerebrospinal fluid (CSF) pharmacokinetics of intraventricular vancomycin in patients with staphylococcal ventriculitis associated with external CSF drainage. Clin Infect Dis 1997;25:733-5. https://doi.org/10.1086/513756
  10. Matsunaga N, Hisata K, Shimizu T. An investigation into the vancomycin concentration in the cerebrospinal fluid due to vancomycin intraventricular administration in newborns: a study of 13 cases. Medicine (Baltimore) 2015;94:e922. https://doi.org/10.1097/MD.0000000000000922
  11. Cook AM, Mieure KD, Owen RD, Pesaturo AB, Hatton J. Intracerebroventricular administration of drugs. Pharmacotherapy 2009;29:832-45. https://doi.org/10.1592/phco.29.7.832
  12. LeBras M, Chow I, Mabasa VH, Ensom MH. Systematic review of efficacy, pharmacokinetics, and administration of intraventricular aminoglycosides in adults. Neurocrit Care 2016;25:492-507. https://doi.org/10.1007/s12028-016-0269-3
  13. Klibanov OM, Filicko JE, DeSimone JA Jr, Tice DS. Sensorineural hearing loss associated with intrathecal vancomycin. Ann Pharmacother 2003;37:61-5. https://doi.org/10.1345/aph.1C145
  14. He Z, Wang C, Liu B, Feng M, Wang Z. Successful treatment of serious meningitis caused by extremely carbapenem-resistant Enterobacter cloacae (MIC≥16mg/L) with i.v. meropenem and i.v. amikacin plus intraventricular amikacin. Infect Drug Resist 2019;12:3765-70. https://doi.org/10.2147/IDR.S224509
  15. Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, et al. Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study. J Microbiol Immunol Infect 2014;47:204-10. https://doi.org/10.1016/j.jmii.2012.08.028
  16. Lewin JJ 3rd, Cook AM, Gonzales C, Merola D, Neyens R, Peppard WJ, et al. Current practices of intraventricular antibiotic therapy in the treatment of meningitis and ventriculitis: results from a multicenter retrospective cohort study. Neurocrit Care 2019;30:609-16. https://doi.org/10.1007/s12028-018-0647-0
  17. Wilkie MD, Hanson MF, Statham PF, Brennan PM. Infections of cerebrospinal fluid diversion devices in adults: the role of intraventricular antimicrobial therapy. J Infect 2013;66:239-46. https://doi.org/10.1016/j.jinf.2012.11.006
  18. Tangden T, Enblad P, Ullberg M, Sjolin J. Neurosurgical gram-negative bacillary ventriculitis and meningitis: a retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis 2011;52:1310-6. https://doi.org/10.1093/cid/cir197
  19. Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, et al. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care 2015;30:218.e1-218.e5. https://doi.org/10.1016/j.jcrc.2014.09.020
  20. Grabb PA, Albright AL. Intraventricular vancomycin-induced cerebrospinal fluid eosinophilia: report of two patients. Neurosurgery 1992;30:630-4. https://doi.org/10.1097/00006123-199204000-00029